Please login to the form below
Argos Therapeutics
This page shows the latest Argos Therapeutics news and features for those working in and with pharma, biotech and healthcare.
VC raises new €270m fund for European biotechs
It currently has around 25 companies in its portfolio, including Dutch gene therapy specialist UniQure, UK women’s health start-up KaNDy Therapeutics and US biotech Argos Therapeutics which as an
Latest news
-
Argos hit as kidney cancer immunotherapy fails phase III trial
Argos Therapeutics' hopes of bringing lead cancer immunotherapy rocapuldencel-T to market anytime soon have been dashed after it flunked a pivotal phase III trial. ... Shares in Argos lost two-thirds of their value after the news broke as investors grew
-
BMS signs $975m deal for Bavarian Nordic cancer vaccine
Last year for example, Boehringer Ingelheim licensed rights to CureVac's investigational therapeutic cancer vaccine CV9202 - which it plans to test alongside its Giotrif (afatinib) product - while Argos Therapeutics and Northwest
-
Developing therapeutic cancer vaccines
AGS 003 consists of dendritic cells that have been loaded with whole tumour RNA using Argos Therapeutics' proprietary Arcelis Personalised Immunotherapy Platform.
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
Featured jobs
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Global Business Development Director – Health Education
-
excellent commission
-
Account Director, Medical Education
-
Salary TBC
-
Associate Director
-
£75, 000-90, 000
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Account Manager / Account Director
-
Competative
-
Senior Medical Writer
-
Salary TBC
-
Medical Writer
-
Salary TBC
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
Subscribe to our email news alerts
- Europe closer to biosimilar rule change, despite fierce resistance from pharma
- Immunomedics craters after FDA rejects breast cancer ADC
- NHS England sees off AbbVie's Hep C legal challenge
- FDA expecting boom in cell and gene therapies
- Moving annual total (MAT)
- Novartis forges AI alliance with Oxford University
- Unlocking the potential of science and technology in the UK
- A Magical Future – A year on from the graduate scheme
- Rising economic risk casts shadow on Davos meeting
- Vertex gains EU approval for earlier Orkambi use
- Neoantigen player Achilles gets OK for first clinical trial
- Star Europe kicks off 2019 in style
PMHub
Anthill Agency
Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...
Latest intelligence
- Unlocking the potential of science and technology in the UK
- Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
- NHS regional footprints
- What to expect from 2019...
- Not another weight-loss ad
- Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
Quick links
Infographics
